Patents Assigned to Altum Pharmaceuticals Inc.
  • Patent number: 11135212
    Abstract: A method for treating osteoporosis and related methods are disclosed. The methods generally comprise administering to a patient in need of treatment an effective amount of tris(8-quinolinolato)gallium(III) or an analog thereof.
    Type: Grant
    Filed: October 31, 2019
    Date of Patent: October 5, 2021
    Assignee: Altum Pharmaceuticals Inc.
    Inventor: Hooshmand Sheshbaradaran
  • Patent number: 10933021
    Abstract: The present invention relates to dosage forms of gallium complexes suitable for oral delivery and methods of preparation thereof. Such dosage forms are useful for the treatment of diseases, including, but not limited to, cancer.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: March 2, 2021
    Assignee: Altum Pharmaceuticals Inc.
    Inventors: Rickey Roy Rhinebarger, Gina G. Stetsko
  • Publication number: 20200061048
    Abstract: A method for treating osteoporosis and related methods are disclosed. The methods generally comprise administering to a patient in need of treatment an effective amount of tris(8-quinolinolato)gallium(III) or an analog thereof.
    Type: Application
    Filed: October 31, 2019
    Publication date: February 27, 2020
    Applicant: Altum Pharmaceuticals Inc.
    Inventor: Hooshmand SHESHBARADARAN
  • Patent number: 10548849
    Abstract: The present invention relates to dosage forms of gallium complexes suitable for oral delivery and methods of preparation thereof. Such dosage forms are useful for the treatment of diseases, including, but not limited to, cancer.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: February 4, 2020
    Assignee: Altum Pharmaceuticals Inc.
    Inventors: Rickey Roy Rhinebarger, Gina G. Stetsko
  • Patent number: 10463657
    Abstract: A method for treating osteoporosis and related methods are disclosed. The methods generally comprise administering to a patient in need of treatment an effective amount of tris(8-quinolinolato)gallium(III) or an analog thereof.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: November 5, 2019
    Assignee: Altum Pharmaceuticals Inc.
    Inventor: Hooshmand Sheshbaradaran